- Home
- CELZ vs HSCS Comparison
CELZ vs HSCS Comparison
Compare CELZ & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- HSCS
- Stock Information
- Founded
- CELZ 1998
- HSCS 2007
- Country
- CELZ United States
- HSCS United States
- Employees
- CELZ N/A
- HSCS N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- HSCS Medical Specialities
- Sector
- CELZ Health Care
- HSCS Health Care
- Exchange
- CELZ Nasdaq
- HSCS Nasdaq
- Market Cap
- CELZ 10.4M
- HSCS 9.9M
- IPO Year
- CELZ N/A
- HSCS 2022
- Fundamental
- Price
- CELZ $3.09
- HSCS $3.03
- Analyst Decision
- CELZ
- HSCS Strong Buy
- Analyst Count
- CELZ 0
- HSCS 2
- Target Price
- CELZ N/A
- HSCS $10.50
- AVG Volume (30 Days)
- CELZ 169.9K
- HSCS 33.1K
- Earning Date
- CELZ 11-07-2025
- HSCS 12-15-2025
- Dividend Yield
- CELZ N/A
- HSCS N/A
- EPS Growth
- CELZ N/A
- HSCS N/A
- EPS
- CELZ N/A
- HSCS N/A
- Revenue
- CELZ $6,000.00
- HSCS $6,250.00
- Revenue This Year
- CELZ N/A
- HSCS N/A
- Revenue Next Year
- CELZ N/A
- HSCS N/A
- P/E Ratio
- CELZ N/A
- HSCS N/A
- Revenue Growth
- CELZ N/A
- HSCS N/A
- 52 Week Low
- CELZ $1.69
- HSCS $2.52
- 52 Week High
- CELZ $6.90
- HSCS $6.47
- Technical
- Relative Strength Index (RSI)
- CELZ 45.24
- HSCS 44.12
- Support Level
- CELZ $2.77
- HSCS $2.88
- Resistance Level
- CELZ $3.34
- HSCS $3.15
- Average True Range (ATR)
- CELZ 0.47
- HSCS 0.19
- MACD
- CELZ -0.05
- HSCS 0.03
- Stochastic Oscillator
- CELZ 17.24
- HSCS 53.62
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.